Elevated levels of inactivated phospho ATG13 have been previously reported [14] in the plasma samples of ME/CFS patients, indicating that the current findings are highly pertinent to the pathogenesis of ME/CFS. The gene discussed is ATG13; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.